control group:Intravaginal administration of recombinant human interferon alpha 2b vaginal effervescent capsules (cinfenine)

2 trials

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Conditions

Cervical high risk human papillomavirus (HPV) infection continues

Early Phase 1

A multicenter, randomized, controlled study of a novel detoxifying, detoxifying, detoxifying, detoxifying, and regulating vaginal microecology in the treatment of persistent cervical human papillomavirus infection at high risk

RecruitingChiCTR2000037212

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese MedicineCervical high risk human papillomavirus (HPV) infection continues

Start: 2020-09-01Updated: 2020-10-13

A multicenter, randomized, controlled study of a novel detoxifying, detoxifying, detoxifying, detoxifying, and regulating vaginal microecology in the treatment of persistent cervical human papillomavirus infection at high risk

RecruitingITMCTR2000004006

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese MedicineCervical high risk human papillomavirus (HPV) infection continues

Start: 2020-09-01Updated: 2023-02-20